Introduction
Telomerase is a speci®c enzyme that prevents telomere erosion at each round of DNA replication. In the absence of telomerase, the length of the reiterated telomere sequences, (TTAGGG)n in human, should processively shorten because of the end replication problem (Watson, 1972) . Using cultured cells and cell lines, evidence for a close correlation between telomere length and the capacity of proliferative potentials has been documented (Allshire et al., 1988 (Allshire et al., , 1989 Moyzis et al., 1988; Harley et al., 1990; Harley, 1991 Harley, , 1995 Hastie et al., 1990; Wilkie et al., 1990; Yu et al., 1990; Allsopp et al., 1992; Levy et al., 1992; Counter et al., 1992 Counter et al., , 1994a Kruk et al., 1995) . On the other hand, it has been demonstrated that activated telomerase is evidently associated with more than 85% of cancer cells and the majority of established cell lines but is undetectable in normal cellular counterparts (Kim et al., 1994) . However, we and others have demonstrated that telomerase activities are detectable at a weak but signi®cant level in cultured normal human epidermal keratinocytes (Yasumoto et al., 1996; Harle-Bachor and Boukamp, 1996) and are enriched in the integrin b1 bright cell subset (Yasumoto et al., 1996) . This is not restricted to epidermal basal cells but also true in other regenerating epithelial tissues such as uterine cervix (Yasumoto et al., 1996) and endometrium (Kyo et al., 1996) . It has also been demonstrated that a normal hematopoietic cell lineage has similar weak telomerase activity (Counter et al., 1995; Hiyama et al., 1995; Morrison et al., 1996a; Chiu et al., 1996) . Telomere shortening, however, occurs in hematopoietic cell lineages (Counter et al., 1995) which are subject to aging (Morrison et al., 1996b) , implying that the expression levels of the telomerase in these cells may be insucient for the prevention of telomere erosion.
Although the biological signi®cance of the telomerase activity detectable at low levels in various regenerative normal cells remains unde®ned at present, it is potentially important for the following two reasons: (1), telomerase activity could be a useful diagnostic marker for cancers and telomerase itself is a possible target molecule for cancer treatment, thus telomerase activities in normal cells would hamper the eective performance for such applications; (2), since telomerase activity in normal cells appears to be closely associated with cell reproductive potential, it is conceivable that telomerase activity, though not strong enough to maintain telomeres, plays a role in the reproduction and maintenance of regenerating somatic tissues. One of underlying questions is whether telomerase activity could be regulated during the course of cell growth and dierentiation. Recently, it was shown that telomerase activity was downregulated when cell growth was inhibited by cell cycle inhibitors (Zhu et al., 1996) or the cells became quiescent in vitro (Sharma et al., 1995; Albannell et al., 1996; Bestilny et al., 1996; Holt et al., 1996) . These previous studies suggest that telomerase activity is regulated in the process of cell growth and differentiation. However, the control of telomerase activity may not be directly linked to a speci®c event in cell cycle . These contradictory results may be attributed that most cell types used in the previous studies were immortalized cell lines in which telomerase activation had already occurred, possibly because of deregulation of genes for telomerase-related components such as a catalytic subunit (Weinrich et al., 1997) .
In this study, we ®rstly attempted to determine whether regulatory expression of telomerase activity could be the case in normal cells and found that the activity was associated with the DNA synthetic activity of primary normal human epithelial cells. We further examined the telomerase positive and negative cells among heterogeneous cell subsets constituting a normal human epithelial cell population. The epithelial cell compartments were fractionated from the primary human epithelial cell population using several monoclonal antibodies against cell surface marker proteins, such as epidermal growth factor receptor (EGFR), low anity nerve growth factor receptor (p75 NGFR ) and integrin subfamilies (b1 and b4). Several distinct celltypes which dierentially express these receptor proteins were dissociated from the primary normal epithelial cells of uterine cervix. We show here that telomerase activity is predominantly associated with the actively proliferating cell fraction which strongly expresses integrin b1, EGFR and Ki-67. Moreover, the activity is down-regulated in a speci®c basal cell subset which expresses p75 NGFR , integrin b4 and bcl-2 proteins. The present study provides evidence that the telomerase activity is inducible in a epithelial cell subset upon cell growth. The activity increases in S phase followed by a sharp decrease in the post-S phase in normal human epithelial cells, suggesting that telomerase activity is regulated in the cell cycle of normal human epithelial cells and necessary for cell reproductive potential in general and not merely for cancer cells.
Results
Telomerase activity is induced upon cell growth in primary normal human epithelial cells
Freshly prepared primary human epithelial cells were plated at a density of 2.0610 4 per cm 2 in Collagen IVcoated dishes, then approximately 60 ± 75% of the plated cells were allowed to multiply during the following 72 h. Cell growth plateaued at a density of about double ( Figure 1A ). The DNA synthesis in normal cells reached its peak on the third day after plating and declined thereafter. The telomerase activity increased in the growing phase and became evident at 72 h when the DNA synthetic activity reached its peak, and then sharply declined thereafter ( Figure 1B) . In contrast, a constant telomerase expression was observed in an immortal cell line (NCC16) during the course of cell proliferation. Telomerase activities in NCC16 cells were not parallel with increases of DNA synthetic activity even in the diluted extracts. ( Figure  1C ). Although telomerase activities are not strictly quantitative, these results provide evidence that regulatory expression of telomerase activity occurs in normal cells but is undetectable in an immortal cell line in which the activity is at least several hundred fold Figure 1 Correlations between telomerase activities with the cell proliferation and DNA synthetic activities of cultured epithelial cells of normal human uterine cervix and an immortalized cell line, NCC16. (A) Primary human epithelial cells obtained from the explant cultures of endo-cervical tissue (NCC) were plated in triplicate at a density of 2.0 6 10 4 cells/cm 2 in 35 mm collagen IVcoated culture dishes. In parallel, NCC16 cells were plated at slightly lower cell density because of their higher plating eciency than primary cells so that the growth of cells would be comparable. The DNA synthetic ability was measured by the incorporation of [ Figure 1B) . Since the epithelial cell population, however, constitutes proliferatively heterogeneous cell compartments (Lavker and Sun, 1982; Barrandon and Green, 1987; Jones and Watt, 1993) , further analysis was focused on the characteristics of the telomerase-positive and -negative epithelial cell subsets.
Not all basal cells have telomerase activity
To explore the speci®c basal cell subsets with and without telomerase activity, we ®rst fractionated proliferatively heterogeneous basal cell subsets from uterine cervical epithelial cells using anti-integrins (b1, b4) and anti-p75 Figure 2A , ®rstly, 5.0 6 10 6 NCC cells were separated into integrin b1-negative and positive cells. Integrin b1-negative cells were further fractionated with antibodies against p75 NGFR and EGFR. This fractionation procedure, though not strictly quantitative, dissociated the subpopulation dully-expressing . RNaseA-sensitivities of the activity detected in lanes 6 ± 9. (c). Evaluation of the presence or absence of inhibitory eects in the telomerase negative fractions by mixing the extracts. The number for the lanes (1 to 9) in B corresponds to the number of the fractions (1 to 9) in A integrin b1 (integrin b1-) into at least four subsets: integrin b1-/p75 NGFR +, integrin b1-/p75 NGFR 7, integrin b1-/EGFR+ and integrin b1-/EGFR7. In addition, there was an apparent subset which expresses signi®cant amounts of both p75 NGFR and EGFR but not integrin b1 ( Figure 2A , fraction 2). All these integrin b1 negative subsets have no or very little telomerase activity (Figure 2A ). These results further con®rmed our previous result that telomerase activity is not properly associated with the integrin b1-. A trace amount of the activity, however, was detectable in the fraction of p75 NGFR +/EGFR+/integrin b1-( Figure 2B , lane 2).
Telomerase is predominantly associated with subsets expressing integrin b1 and EGFR To characterize telomerase-positive subsets, we took another approach for the cell fractionation in parallel in which telomerase-negative (p75 Figure 2A ) and could not be dierentiated into a speci®c subset among the fractions. No telomerase activity was associated with a small subset without EGFR (data not shown). The result is consistent with the characteristics of the telomerase positive cells that have highly proliferative potentials (Yasumoto et al., 1996) . In contrast, no or very little telomerase activities were reproducibly detected in integrin b1-negative fractions even in the increased amounts of the cell extract (data not shown). The activities in the telomerase positive fractions were RNaseA-sensitive ( Figure 2Bb ). The reconstitution experiments excluded the possibility that the telomerase negative fraction contains inhibitory factors linked to the enzymatic process of the telomerase assay, because the cell extracts with no telomerase activity did not abrogate the telomerase activity in the integrin b1-positive cell extracts (Figure 2Bc ).
Telomerase negative p75
NGFR expressing cells are a small subset of basal cells
To characterize growth properties of the telomerase negative p75 NGFR -expressing cells as well as the other cellular subsets, freshly dissected tissue specimens from NCC and NCE were subjected to explant culture. They can be multiplied over several months in vitro, retaining speci®c cellular phenotypes that re¯ect their cellular origins (Tsutsumi et al., 1993; Ohta et al., 1997) . The¯ow-cytometric analysis shows that almost all cells in the explant cultures are positive for EGFR and integrins, suggesting that the cell population predominantly contains cell fractions derived from basal and suprabasal layers ( Figure 3A ). This is consistent with the immunohistochemical observations (data not shown), though expression levels appear to vary among the individual cells. Notably, p75 NGFR -positive cells were undetectable in the primary cell population by Regulatory expression of telomerase in normal cells C Kunimura et al ¯owcytometry ( Figure 3B, a and b) . Western-blot analysis further con®rmed that p75 NGFR protein was detected only at low levels in the primary NCC and NCE cells ( Figure 3C, lanes a and b) . The expression levels were parellel with that of thē owcytometric analysis ( Figure 4C ). This suggests that p75 NGFR -expressing cells undergo only a few round of mitosis for the period in culture, while the growth of macrocolony has proceeded at least 10 population doubling for the following several weeks after the removal of the original explant. These observations support the notion that the telomerase negative p75 NGFR -expressing cells are a slowly cycling epithelial cell subset in vitro. Alternatively, it is possible that p75 NGFR is expressed only in progenitor cells and down-regulated shortly after cell division.
To further characterize the p75 NGFR -expressing cells, the fractionated cells were examined for the expression of bcl-2 which is known as a factor for the promotion of cell survival (Polakowska et al., 1994; Reed, 1994) . The p75 NGFR -positive cells were puri®ed to up to 90% homogeneity from 1.0 6 10 6 primary NCC and NCE cells by the DAB method as described ( Figure 5A ). Western blots of these fractions equivalent to 1.5 6 10 4 cells demonstrated that bcl-2 protein was tenfold more abundant in the p75 NGFR -positive cell fractions of both NCC and NCE cells ( Figure 5B ). The result clearly shows that p75
NGFR is co-expressed with bcl-2 in the speci®c small basal cell subset of uterine cervix. We noted that the fraction contained some p75 NGFR -positive cells undergoing cellular-mitosis at frequencies of about 1% or less in the fractionated cell population ( Figure  5C ) and very weak telomerase activity was occasionally detected ( Figure 5D , lane N+). It is therefore likely that p75 NGFR expressing cells can divide but have a poor proliferating activity in vitro.
Immunohistochemical examination of p75 NGFR in the epithelial tissues of the endo-cervix (NCC) and ectocervix (NCE) shows that p75 NGFR -expressing cells are present in these dierent epithelial tissue types. Notably, they are localized in a restricted region of the basal layer forming patches (Figure 6Aa and 6Ba) . The location of the p75 NGFR -expressing cells is distinct from that of the Ki-67 positive cells in both NCC and NCE ( Figure 6A , b, c, d and e; Figure 6B , b, c), suggesting that they are dully-cycling in vivo as well as in vitro. 
Discussion
Telomerase activity has been detected in various normal human somatic cells in regenerating tissues such as the epidermis (Yasumoto et al., 1996,; HarleBachor and Boukamp, 1996) , small intestine, lymphnode, esophagus (our unpublished results), uterine cervix (Yasumoto et al., 1996.) and endometrium (Kyo et al., 1997) as well as in leukocytes (Counter et al., 1995) and bone marrow precursor cells (Hiyama et al., 1995; Chiu et al., 1996; Morrison et al., 1996a,b) . All these previous observations indicate that telomerase activity is ubiquitously found in many proliferatively active somatic cells except for ®broblasts. Telomerase activities detected in the normal cell population are generally weaker than those of most cancer cells and immortalized cell lines. However, the activity can be enriched in certain cell fractions (Hiyama et al., 1995; Yasumoto et al., 1996) , suggesting that telomerase activation occurs under physiological conditions among various regenerating tissues. Recent studies argue that telomerase activity is regulated in the cell cycle, because the activity is linked to the proliferative potential and declines when the cells exit the cell cycle in the process of dierentiation (Sharma et al., 1995; Holt et al., 1996; Albannell et al., 1996; Bestilny et al., 1996) . By using a synchronized cell population, it was also shown that telomerase activity was regulated in the cell cycle (Zhu et al., 1996) . However, Holt et al. (1997) claim that telomerase activity in immortalized cell lines, which is usually detected at high levels, remained constant during the cell cycle when non-cytotoxic cell cycle blockers were used. Although this may not be contradictory to the notion that telomerase activity generally correlates with growth rate and is suppressed in the cells that exit the cell cycle and become quiescent, it still remains undetermined whether or not telomerase activity is regulated in association with any speci®c events in the cell cycle of normal cells. In the present study, we demonstrated that telomerase activity increased in S phase and sharply decreased in post-S phase by using freshly prepared primary human epithelial cells. The result implies that telomerase regulation is linked to the cell cycle in primary human epithelial cell populations but not immortal cell lines. Since, unlike most cancer-derived cell lines, normal cells, particularly epithelial cells, constitute heterogeneous cell subsets in terms of cell growth and dierentiation, it is of interest to examine whether or not the regenerating epithelial cell population contains telomerase positive and negative cell types. Proliferatively heterogeneous epithelial cell subsets were separable by means of immunocytochemical cellsorting. We used several monoclonal antibodies against cell growth-related cell surface receptors which dierentially expressed among cell types in dierent stages of the cell cycle. Telomerase positive cells were identi®ed as a speci®c subset which strongly expressed integrin b1 and EGFR. The result con®rmed our previous observations that telomerase activity was enriched in the cells that rapidly adhered to collagen type IV. This cell subset has been shown to have highly proliferating activity in vitro (Jones and Watt, 1993; Jones et al., 1995; Yasumoto et al., 1996) , suggesting that this cell fraction contains reproductive precursor cells.
In addition to the telomerase-positive cells, we also characterized the telomerase-negative epithelial cell subset and identi®ed p75 NGFR -expressing basal cell subset in which telomerase is down-regulated. The telomerase-negative p75 NGFR -expressing cells shown in the present study reside in the basal but not suprabasal layer of the squamous epithelium, suggesting that they are not likely to be committed toward terminal dierentiation. Unlike in epidermal squamous epithelium, it is known that actively proliferating Ki 67-positive cells predominantly reside in the suprabasal but not basal layer in many wet epithelial tissues such layer. A number of previous studies agree that bcl-2 acts against cell proliferation, cell death, apoptosis and dierentiation in many normal cell types (Buck et al., 1987; Sariola et al., 1991; Polakowska et al., 1994; Reed, 1994 for a review; Harada et al., 1998) . In this context, the p75 NGFR -expressing basal cell subset is distinct from a specialized cell type committed toward terminal dierentiation. Since bcl-2 is assumed to be a cell survival factor, strong expression of bcl-2 protein in p75 NGFR -positive cells may play a role in the negative regulation of cell growth. This agrees with the observation that p75 NGFR -positive cells are a subset of the Ki-67 negative population in vivo. Our conclusion may be relevant to the recent report that very high expression of bcl-2 modulates telomerase expression (Mandel and Kumar, 1997) .
Co-localization of p75 NGFR with integrin b4 but not integrin b1 favours the above presumption and is consistent with the previous notion that integrin b4 is not correlated with proliferative potential in vitro (Jones et al., 1995) . Integrin b4 is another cellular attachment receptor which forms a a6b4 heterodimer in many epithelia (Stepp et al., 1990; Sonnenberg et al., 1991) and is required for cell adhesion on basal lamina via laminins (Kajiji et al 1989; Carter et al., 1990) , forming hemidesmosomes (Jones et al., 1991;  A B NGFR -positive cells (Hematoxylin-eosin staining). CE, columner epithelium; S, stroma Sonnenberg et al., 1991; Dowling et al., 1996) . Considering previous cell kinetic analyses that stem cells divide only rarely under normal steady-state conditions (Potten and Morris, 1988; Cotsarelis et al., 1990; Lavker et al., 1991; Loeer and Potten, 1997) , our present observations lead us to propose that the p75 NGFR -expressing cells are a speci®c basal cell subset, such as precursor cells, of the regenerating human epithelial tissues (Loeer and Potten, 1997). The cellular characteristics associated with p75 NGFR -expressing cells that stay at Go phase in the basal layer in vivo and enter the cell cycle under certain conditions are analogous to a more primitive stem cell population of the blood cell system, which is out of the cell cycle and telomerase-negative (Hiyama et al., 1995; Chiu et al., 1996; Morrison et al., 1996a,b) , suggesting that p75 NGFR expressing cells are involved at least in part in homeostasis of cell recruitment and maintenance of epithelial tissues.
In conclusion, the present study clearly shows that telomerase is silent in p75 NGFR -expressing cells and active in the S phase in proliferating cells which predominantly express integrin b1 and EGFR. The regulatory expression of telomerase in normal cells may be associated with more general biological events such as genomic stability in actively proliferating normal human epithelial cells, though expression levels are relatively low compared to most immortal cell lines. Although the biological implications of the telomerase activity detected in various normal cells remains unclear, the present results favour that targetting telomerase is not a hazard to the majority of p75 NGFR -expressing reserve cells, unless they are stimulated to divide. This possibility should be tested for future clinical cancer treatment using putative telomerase inhibitors.
Materials and methods

Preparation of normal human epithelial cells
Normal human epithelial cells were prepared from uterine cervixes surgically removed from patients with severe uterine myoma. To isolate the epithelial cell population, endo-cervical and ecto-cervical tissue specimens (approximately 162 cm 2 ) were incubated in 1000 m dispase (GIBCO ± BRL. Inc) at 48C overnight. The detached ecto-cervical epithelium was minced into small pieces (16cm 2 ) and incubated in Ca 2+ , Mg 2+ free PBS (PBS7) containing 0.01% EDTA solution at 48C for 20 min then pipetted several times. The dissociated single cells were collected through 80 platinum mesh. Alternatively, epithelial cells were prepared from the explant culture in MCDM153 medium containing 0.1 mM Ca 2+ for endocervical simple epithelial cells and DMEM/MCDB (1/4) medium for ecto-cervical keratinocytes . Outgrowing epithelial cells from explants cultured for 2 ± 4 weeks on collagen IV-coated culture dishes (Falcon Inc.) were recovered by treatment with 0.01% EDTA-PBS (7) for 15 min at 48C following digestion with dispase at 258C for 20 min. The dissociated cells were processed to secondary cultures or stored in liquid nitrogen until use. Approximately 10 7 primary cells can be harvested from explant cultures prepared from 162 cm 2 pieces of epithelial tissue. Endocervical simple epithelial cells (NCC) and ecto-cervical keratinocytes (NCE) were separately cultured in MCDB153 medium containing a low Ca 2+ concentration (0.03 mM) supplemented with hormone mixtures and, if necessary, bovine pituitary extracts (75 mg proteins/ml). These cells were serially cultivated by 1 : 5 splits for at least ®ve passages in a humidi®ed 5% CO 2 atmosphere at 378C as described (Yasumoto et al., 1992) .
Cell lines
HPV16-transformants: NCC16 and NCE16 are HPV16-immortalized cell lines of NCC and NCE cells, respectively. All these cell lines were established after transfection of human papillomavirus type 16 (HPV16) DNA. The characteristics of these cell lines have been described (Yasumoto et al., 1992; Tsutsumi et al., 1993; . NCE16N+ is a clonal variant strongly expressing p75
NGFR isolated from the parental NCE16 in this study.
The measurement of cell growth and DNA synthesis
The cells were plated in triplicate at a concentration of 1 ± 2 6 10 5 cells/35 mm collagencoated dish. The number of viable cells attached within 6 h after plating were counted to determine the plating eciency. Then, the cells were refed with 2.0 ml fresh medium. The growth of cells was measured by counting the cells every 24 h, using a hemocytometer. To determine the DNA synthetic ability, 1 mC of [ 3 H]thymidine was added to the cultures containing 1.0 ml of the fresh medium at 6 h after plating, then incubated for 16 h in the CO 2 incubater. The incorporation of [
3 H]thymidine into the TCA insoluble fraction was measured with a liquid scintillation counter, MINAXIb TRI-CARB r 4000 (United Technol. Packard). Measurement of DNA synthesis was carried out every 24 h.
Antibodies
The monoclonal antibodies used in this study are: antiintegrin b1 (clone P4C10, Life Tech.), anti-integrin b4 (clone 3E1, Chemicon Int. Inc.), anti-NGFR (clone 8211, Boehriger-Mannhaim), anti-EGFR (clone 528, CALBIO-CHEM), anti-bcl-2 (clone 124, DAKO) and anti-Ki-67 (clone Mib-1, IMMUNOTECH Co.). All these antibodies were used as recommended by the suppliers. The applied conditions are described more speci®cally in each experimental procedure.
Immunohistochemical staining
Tissue specimens were ®xed with 10% paraformealdehide for 30 min and paran embedded samples were prepared by conventional histological methods. Tissue sections of 4 mm thickness were processed for immunohistologic examination using the streptoavidin-biotin SAB method as follows. Tissue sections brie¯y rinsed with distilled water were treated with absolute ethanol containing 3% hydroxyl peroxide to block endogenous peroxidase for 30 min at 258C and then washed with phosphate buered saline containing 0.5% Tween 20 for 5 min. To sensitize antigenic epitopes, the samples were treated with 10 mM citric acid (pH 6.0) at 908C for 1 h and then rinsed three times with phosphate buer containing 0.5% Tween 20. The samples were treated with blocking reagent containing 10% normal rabbit serum for 15 min at 258C then immunoreacted with the ®rst antibodies by incubating at 48C overnight. The samples were then treated with biotin-labeled second antibody for 10 min at 258C and reacted with streptoavidin-conjugated peroxidase for 5 min at 258C. The enzymatic products were stained in Tris-HCl buer (pH 7.6) containing 3, 3'-diaminobentidin (DAB) and 1 nM hydroxyl peroxide. Hematoxilin was used for counter staining, if necessary.
Flow-cytometry
Flow cytometry was performed using a FACScan (BectonDickinson) as described previously (Yasumoto et al. 1991 . The preparation of cells for the FACScan assay was carried out as recommended by the supplier. Brie¯y, the cells were treated with ®rst antibodies at a concentration of 1 mg/ml, then with FITC-conjugated anti-mouse IgG (1 mg/ml). The¯uorescent intensity of the 1610 4 labeled cells was monitored by detecting FITCuorescence.
Fractionation of the epithelial subpopulation by the Dynabeads method
Cells either from tissue specimens or explant cultures were dissociated by treatment with ®ve caseinolytic m/ml Dispase (Collab. Biomed.) at 258C for 30 min. The cell pellets were washed twice with 0.01% EDTA-PBS(7), then incubated in the same buer for a further 15 min to dissociate all cell clumps to a single cell suspension. The dissociated cells were washed three times with cold PBS7 and resuspended in an appropriate volume of PBS-for the following cell fractionation experiment. Typically, the cell concentration settled at 1.0610 7 cells/ml, proportionally increasing or decreasing depending on the manipulating cell numbers. First antibodies were added at a concentration of 250 ng/ ml in a small volume of cell suspension, then incubated at 258C for 15 min and on ice for 15 min with constant agitation. The cells were then washed with PBS-three times and resuspended into new tubes at a concentration of 1.0610 7 /ml with PBS7. The cells were mixed with IgGconjugated magnetic particles (DynaBeads M-450, DYNA-LAS Co. Norway) as recommended by the supplier (The DAB method). Brie¯y, Dynabeads were added at a ratio of four particles/one cell, incubated gently with agitating at 258C for 15 min, then placed on ice for 15 min. Cells bound to Dynabeads were separated under magnetic ®elds using Dynal MPC R -M for 1 min. Unbound cells were recovered, washed three times with PBS7, then processed for further fractionation using dierent antibodies or used for various assays. Bound cells were treated with 10 m/ml chymopapain (Sigma, Co. USA) at 378C for at least 45 min to detach the Dynabeads. The recovered cells were used for further fractionation with dierent antibodies or directly used for assays.
Western blotting
The cells expressing the p75 NGFR were fractionated from explant cultures of endocervical (NCC) or ectocervical (NCE) keratinocytes as described. The unfractioned, p75 NGFR positive-or negative-cells were dissolved in the loading buer (62.5 mM Tris-base, 10% glycerol, 5% 2-mercaptoethanol, 2.3% SDS, pH 6.8) for SDS-polyacrylamide gel electrophoresis to yield equal cell densities. The lysates were boiled for 5 min, sonicated for 1 min by using the Biorupter micro-sonicator model UCD-200 (TOSHO DENKI Co. Yokohama), then centrifuged for 5 min at 15 000 r.p.m. to remove cell debris and Dynabeads. The proteins were separated on 12.5% SDS-polyacrylamide gel and blotted to PVDF membranes (Milliore) as described previously . Bcl-2 and p75 NGFR were detected using anti-bcl-2 (DAKO) mouse monoclonal antibody and anti-NGFR antibody (clone 8211, Boehriger-Mannhaim), and the Enhanced Chemiluminescence System (Amersham).
Preparation of cell extracts for telomerase assay
The telomerase assay was carried out by a method described previously (Kim et al., 1994) with slight modi®cation (Yasumoto et al., 1996) . Brie¯y, cells were harvested by trypsin-EDTA treatment and viable cells were counted after staining with trypan-blue. One to two610 5 cells were washed once in 1.5 ml of phosphate buered saline, and pelleted at 4000 g for 5 min at 48C. The cell pellet was either quickly frozen in liquid nitrogen until use or directly suspended at 1000 cells/m1 in ice cold lysis buer consisting of 10 mM Tris-HCl (pH 7.5), 1 mM MgCl 2 , 1 mM EDTA, 5 mM b-mercaptoethanol, 0.1 mM AEBSF (4-(2-aminoethyl)-benzenesulfonyl¯uoride hydrochlorine), 0.5% CHAPS (3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate), and 10% glycerol. Cell extracts were kept on ice for 30 min then centrifuged at 15 000 g for 30 min. The supernatant was recovered and either quickly frozen in liquid nitrogen or used for the assay.
Assay of telomerase activity
For the detection of the telomerase activity, we mostly employed the conventional method of TRAP (telomeric repeat ampli®cation protocol) assay which was originally developed by Kim et al. (1994) . Brie¯y, the reaction mixture for one telomerase assay (25 ml) consisted of 20 mM Tris-HCl (pH 8.5), 1.5 mM MgCl 2 , 63 mM KCl, 0.005% Tween 20, 1 mM EGTA, 50 mM deoxyribonucleotide triphosphates (dNTP), 0.05 mg TS primer (5'-AATCCGTCGAGCAGAGAGTT-3'), 0.5 mM T4g32 protein (Boehringer-Mannheim Inc.), 2 mCi a-[
32 P] deoxycytidine triphosphate (dCTP, 3000 Ci/mmol, DuPont/NEN Res. Products), 1 m Taq DNA polymerase (BoehringerMannheim) and 1 ± 5 ml (equivalent to 1000 ± 5000 cells) of the cell extract. The extracts were either treated or nontreated with 0.2 mg/assay of RNaseA at 258C for 15 min before the telomerase assay. The reaction was started in the thermal cycler, Cyclogene (Techne) or PCR system 9700 (GeneAmp R , PE Applied Biosystems) with one cycle at a setting of 208C for 30 min for extension of oligonucleotides on TS primer by telomerase. The temperature was then set to 908C to inactivate the telomerase and 0.05 mg CX primer (5'-CCCTTACCCTTACCCTTACCCTAA-3') was added. This was followed by 31 cycles at 948C for 45 s, 508C for 45 s, and 728C for 3 min. One ®fth (5 ml) of the reaction mix was analysed on 8% polyacrylamide non-denaturation gels in 16Tris-borate EDTA buer.
Alternatively, approaching the measurement of the activity at a more quantitative level, we employed the modi®ed assay method recently developed by Kim and Wu (1997) . We used unlabelled TS primer instead of the end-labeled TS primer and the ampli®ed products were labeled by the incorporation of a-[ 32 P] deoxycytidine triphosphate (dCTP, 3000 Ci/mmol, DuPont/NEN Res. Products) into the 6-base ladder. This may slightly hamper the quanti®cation but is expected to increase the sensitivity of the detection of telomere extension. Anchored primer ACX (0.05 mg/25 ml reaction mixture), 5'-GCGCGG[CTTACC] 3 CTAACC-3' was added to the reaction mix for the ampli®cation of the telomerase products by the PCR. The internal standard primer set in 25 ml of reaction mix was as follow: TSNT internal control (5'-AATCCGTC-GAGCAGAGTTAAAAGGCCGAGAAGCGAT-3') were 0.05 amol for the transformant and 5610 75 amol for normal cells, and NT internal control primer (5'-ATCGCTTCTCGGCCTTTT-3') was 0.05 mg in the reaction mix. One unit of Taq DNA polymerase (BoehringerManhaim Inc.) and 2 ml CHAPS cell extract (equivalent to 2000 normal cells) was used. The TRAP reaction was started in the thermal cycler, PCR system 9700 (GeneAmp R , PE Applied Biosystems) with one cycle at 308C for 20 min for the extension of oligonucleotides on TS primer by telomerase, then at 948C for 30 s, 608C for 30 s for 32 cycles. An aliquot of the reaction mix (5 ml) was analysed on 8% polyacrylamide non-denaturation gels in 16Tris-borate EDTA buer.
